Immunotherapy (Investigational)

19 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

+63 919 076 9100

Immunotherapy (Investigational) (9)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type	Inquiry
Cibisatamab	CD47 (Macrophage Checkpoint) Inhibitor	Hematologic
Molecule Cibisatamab Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Etentamig	Bispecific T-Cell Engager, BCMA x CD3	Hematologic (Multiple Myeloma)
Molecule Etentamig Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Bispecific T-Cell Engager, BCMA x CD3
Evorpacept	CD47 (Macrophage Checkpoint) Inhibitor	Hematologic
Molecule Evorpacept Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Forimtamig	Bispecific T-Cell Engager, GPRC5D x CD3	Hematologic (Multiple Myeloma)
Molecule Forimtamig Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Bispecific T-Cell Engager, GPRC5D x CD3
IBI322 (CD47/PD-L1)	CD47 (Macrophage Checkpoint) Inhibitor	Hematologic
Molecule IBI322 (CD47/PD-L1) Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Lemzoparlimab	CD47 (Macrophage Checkpoint) Inhibitor	Hematologic
Molecule Lemzoparlimab Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Letaplimab	CD47 (Macrophage Checkpoint) Inhibitor	Hematologic
Molecule Letaplimab Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Magrolimab	CD47 (Macrophage Checkpoint) Inhibitor	Hematologic
Molecule Magrolimab Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
TTI-621 (Cibisatamab-related)	CD47 (Macrophage Checkpoint) Inhibitor	Hematologic
Molecule TTI-621 (Cibisatamab-related) Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor

Cibisatamab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Etentamig Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Bispecific T-Cell Engager, BCMA x CD3
Evorpacept Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Forimtamig Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic (Multiple Myeloma) Drug Class / Mechanism Bispecific T-Cell Engager, GPRC5D x CD3
IBI322 (CD47/PD-L1) Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Lemzoparlimab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Letaplimab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
Magrolimab Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor
TTI-621 (Cibisatamab-related) Immunotherapy (Investigational)
Therapeutic Category Immunotherapy (Investigational) Oncology Type Hematologic Drug Class / Mechanism CD47 (Macrophage Checkpoint) Inhibitor